These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 19608262)

  • 1. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z; Sterk PJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukotriene antagonists].
    Mallet JP
    Allerg Immunol (Paris); 1999 Apr; 31(4):113-6. PubMed ID: 10370724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antileukotrienes in the therapy of bronchial asthma].
    Riccioni G; Della Vecchia R; Menna V; Lambo MS; Di Ilio C; D'Orazio N
    Recenti Prog Med; 2003 Nov; 94(11):509-15. PubMed ID: 14679921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antileukotrienes in asthma - critical view].
    Droszcz W
    Pneumonol Alergol Pol; 2010; 78(1):60-7. PubMed ID: 20162520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukotriene agents in asthma: the dart that kills the elephant?
    Renzi PM
    CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of leukotrienes in asthma.
    Wenzel SE
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):145-55. PubMed ID: 12895597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary therapy in asthma: inhaled corticosteroids and what?
    Bjermer L; Diamant Z
    Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based pharmacologic treatment for mild asthma.
    Koh MS; Irving LB
    Int J Clin Pract; 2007 Aug; 61(8):1375-9. PubMed ID: 17590220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukotriene antagonists in the treatment of asthma].
    Mapp CE
    Ann Ital Med Int; 1998; 13(1):24-9. PubMed ID: 9642839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical appraisal of antileukotriene use in asthma management.
    Polosa R
    Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids.
    Maneechotesuwan K; Supawita S; Kasetsinsombat K; Wongkajornsilp A; Barnes PJ
    J Allergy Clin Immunol; 2008 Jan; 121(1):43-50. PubMed ID: 18036645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutic options for asthma.
    Colice GL
    Am J Manag Care; 2011 Apr; 17 Suppl 3():S82-9. PubMed ID: 21761958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.